PatientInformation STARTT study Tuebingen – Katairo

Home
Technology
Development
News
EU Funding
About Us

PatientInformation STARTT study Tuebingen

25. September 2023

Katairo GmbH

Rosentalstr. 5
72070 Tübingen
Germany

info@katairo.com

Navigation

Home
Technology
Development
News
EU Funding
About Us

Information

Legal Notice
Privacy Policy

© 2025 Katairo GmbH 💊 Drug development for seriously disabling eye indications.